These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16275125)

  • 21. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
    Shi L; Pu J; Xu L; Malaguit J; Zhang J; Chen S
    BMC Neurol; 2014 Dec; 14():251. PubMed ID: 25527141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials.
    Uchiyama S; Demaerschalk BM; Goto S; Shinohara Y; Gotoh F; Stone WM; Money SR; Kwon SU
    J Stroke Cerebrovasc Dis; 2009; 18(6):482-90. PubMed ID: 19900653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin.
    McGrath E; O'Conghaile A; Eikelboom JW; Dinneen SF; Oczkowski C; O'Donnell MJ
    Cerebrovasc Dis; 2011; 32(1):22-7. PubMed ID: 21576939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.
    Geng DF; Liu M; Jin DM; Wu W; Deng J; Wang JF
    Cardiology; 2012; 122(3):148-57. PubMed ID: 22832561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan.
    Lee WH; Chu CY; Hsu PC; Su HM; Lin TH; Voon WC; Lai WT; Sheu SH
    Thromb Res; 2013 Aug; 132(2):190-5. PubMed ID: 23433530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis.
    Tan L; Margaret B; Zhang JH; Hu R; Yin Y; Cao L; Feng H; Zhang Y
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):930-8. PubMed ID: 25804574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
    Sakai N; Yamagami H; Matsubara Y; Ezura M; Hyodo A; Matsumaru Y; Miyachi S; Okada Y; Terada T; Yokoi H; Nakamura M; Matsumoto Y; Sakai C;
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1374-84. PubMed ID: 24534127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial.
    Han SW; Lee SS; Kim SH; Lee JH; Kim GS; Kim OJ; Koh IS; Lee JY; Suk SH; Lee SI; Nam HS; Kim WJ; Yong SW; Lee KY; Park JH
    Eur Neurol; 2013; 69(1):33-40. PubMed ID: 23128968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
    Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.